Double Trouble: Interrupting DAPT and COVID-19
Journal of Cardiovascular Emergencies
; 8(2):39-42, 2022.
Article
in English
| Web of Science | ID: covidwho-2082707
ABSTRACT
Cardiovascular disorders have been described as relevant risk factor for severe COVID infection. Stent thrombosis is a life-threatening complication that may occur subacutely. We present an interesting case of a middle-aged woman who developed acute stent thrombosis while interrupting dual antiplatelet therapy (DAPT) ticagrelor, during an episode of coronavirus disease (COVID-19). In our case, the patient's not-compliance to DAPT, associated with COVID-19 infection and a hyperinflammatory and hypercoagulable state associated with it played a major role in the development of stent thrombosis. The hypercoagulable and hyperinflammatory state associated with COVID-19 has important implications for cardiac patients, especially those undergoing complex coronary intervention, predisposing them to an increased risk of post-PCI complications.
Full text:
Available
Collection:
Databases of international organizations
Database:
Web of Science
Language:
English
Journal:
Journal of Cardiovascular Emergencies
Year:
2022
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS